Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 11, Number 6—June 2005

Methicillin-resistant Staphylococcus aureus and Vancomycin-resistant Enterococci in Rural Communities, Western United States

Kurt B. Stevenson*†Comments to Author , Katy Searle†, Gregory Stoddard†, and Matthew H. Samore†‡
Author affiliations: *Qualis Health, Boise, Idaho, USA; †University of Utah School of Medicine, Salt Lake City, Utah, USA; ‡VA Salt Lake City Health Care System, Salt Lake City, Utah, USA

Main Article

Table 5

Random effects Poisson regression model for HA-MRSA* rate†

Predictors No. of institutions Incidence rate ratio 95% CI p value
Quintile of CA-MRSA rate‡
1st–2nd: 0 11 Reference
3rd: 0.3 to 1.6 6 11 2.8–4.5 0.001
4th: 1.7 to 3.4 6 35 10–122 <0.0001
5th: 3.5 to 9.4 5 33 9.2–115 <0.0001
Hospital bed size
13–25 10 Reference
26–50 9 0.8 0.3–2.0 0.596
51–235 9 1.3 0.6–3.0 0.530
Idaho 17 Reference
Utah 11 2.3 1.3–4.2 0.005

*HA-MRSA, heathcare-associated methicillin resistant Staphylococcus aureus; 95% CI, 95% confidence interval; CA-MRSA, community-associated MRSA.
†No. of HA-MRSA cases/10,000 occupied bed-days.
‡No. of CA-MRSA cases/10,000 person-years, based on county population.

Main Article

Page created: April 24, 2012
Page updated: April 24, 2012
Page reviewed: April 24, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.